Vogenx IPO: Jones Trading Led $81.3M Offering
JonesTrading Institutional Services has announced its role as the sole book-running manager for Vogenx, Inc.'s $81.3 million initial public offering. The clinical-stage biopharmaceutical company's shares began trading on the Nasdaq Capital Market on August 12, 2026, with the offering closing on August 13, 2026. This successful capital raise provides Vogenx with funding to advance its therapeutic development.
JonesTrading's role in the Vogenx demonstrates its capital markets platform capabilities for innovative healthcare companies seeking public market access.